Cargando…
Toxicities of Immunosuppressive Treatment of Autoimmune Neurologic Diseases
In parallel to our better understanding of the role of the immune system in neurologic diseases, there has been an increased availability in therapeutic options for autoimmune neurologic diseases such as multiple sclerosis, myasthenia gravis, polyneuropathies, central nervous system vasculitides and...
Autores principales: | Lallana, Enrico C, Fadul, Camilo E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151601/ https://www.ncbi.nlm.nih.gov/pubmed/22379461 http://dx.doi.org/10.2174/157015911796557939 |
Ejemplares similares
-
Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic
por: Kovvuru, Sukanthi, et al.
Publicado: (2021) -
Therapeutic Plasma Exchange as a Treatment for Autoimmune Neurological Disease
por: Nieto-Aristizábal, Ivana, et al.
Publicado: (2020) -
Neurologic Manifestations of Autoimmune Diseases
por: Appenzeller, Simone, et al.
Publicado: (2012) -
Impact and Tolerance of Immunosuppressive Treatments in Patients Living with HIV with Inflammatory or Autoimmune Diseases
por: Guitton, Zélie, et al.
Publicado: (2022) -
Review of Systemic Immunosuppression for Autoimmune Uveitis
por: Castiblanco, Claudia, et al.
Publicado: (2014)